Valuation: Sartorius Stedim Biotech SA

Market Cap 2.07TCr 2.33TCr 1.94TCr 1.76TCr 3.32TCr 2,24400Cr 3.37TCr 23TCr 9.07TCr 1,14300Cr 8.75TCr 8.56TCr 3,67100Cr P/E 2026 *
54.6x
P/E 2027 * 42.2x
Enterprise Value 2.27TCr 2.56TCr 2.12TCr 1.94TCr 3.64TCr 2,46200Cr 3.69TCr 26TCr 9.95TCr 1,25400Cr 9.6TCr 9.39TCr 4,02800Cr EV / Sales 2026 *
7.26x
EV / Sales 2027 * 6.47x
Free-Float
28.47%
Yield 2026 *
0.39%
Yield 2027 * 0.47%
Manager TitleAgeSince
Chief Executive Officer 51 28/03/2023
Chief Tech/Sci/R&D Officer 61 08/09/2011
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 07/04/2015
Director/Board Member 70 07/04/2015
Director/Board Member 69 14/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
-1.28%-3.42%-26.87%+1.96% 17TCr
-0.42%-2.98%-9.42%+10.42% 11TCr
-0.70%+1.30%-24.96%-0.22% 11TCr
-0.69%-0.07%-47.78%-11.65% 7.6TCr
+2.79%-0.58%-1.18%+72.04% 5.73TCr
-0.04%-0.32%-6.44%-30.69% 4.88TCr
+3.44%+7.90%+19.12%+59.15% 5.02TCr
+0.18%+1.72%-15.78%+21.18% 4.11TCr
-0.07%-1.45%+30.46%-8.83% 3.26TCr
Average +0.36%-1.46%-9.21%+12.60% 7.7TCr
Weighted average by Cap. -0.07%-2.07%-15.85%+9.76%

Financials

2026 *2027 *
Net sales 312.72Cr 352.08Cr 292.45Cr 266.5Cr 501.72Cr 34TCr 508.62Cr 3.54TCr 1.37TCr 17TCr 1.32TCr 1.29TCr 55TCr 347.17Cr 390.87Cr 324.67Cr 295.86Cr 557Cr 38TCr 564.65Cr 3.93TCr 1.52TCr 19TCr 1.47TCr 1.44TCr 62TCr
Net income 38Cr 42Cr 35Cr 32Cr 60Cr 4.09TCr 61Cr 426.51Cr 165.11Cr 2.08TCr 159.36Cr 155.91Cr 6.68TCr 48Cr 54Cr 45Cr 41Cr 77Cr 5.22TCr 78Cr 544.4Cr 210.74Cr 2.66TCr 203.41Cr 199Cr 8.53TCr
Net Debt 201.05Cr 226.36Cr 188.02Cr 171.33Cr 322.56Cr 22TCr 327Cr 2.27TCr 880.51Cr 11TCr 849.86Cr 831.43Cr 36TCr 176.38Cr 198.59Cr 164.95Cr 150.31Cr 282.99Cr 19TCr 286.88Cr 2TCr 772.48Cr 9.74TCr 745.59Cr 729.43Cr 31TCr
Logo Sartorius Stedim Biotech SA
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-